[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"weight-maintenance\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:weight-maintenance":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100645574","assessing-follow-up-trajectories-in-eating-routines-and-weight-after-glp-1-100645574",false,"NCT07701460","Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1","AFTER-GLP","Inclusion Criteria:\n\n* 18 years of age or older (no upper limit);\n* ability to read, write, and speak English and\u002For Spanish;\n* ability to provide informed consent;\n* less than 30-days since GLP-1 RA cessation;\n* willing to participate.\n\nExclusion Criteria:\n\n* No clinically significant weight loss (e.g., \\\u003C 5% body weight) while taking GLP medication;\n* major psychiatric illness, cognitive impairment, or substance misuse that could impair ability to participate;\n* medical conditions that significantly affect weight or make participation unsafe (e.g., pregnancy or breastfeeding, recent bariatric surgery, current use of GLP 1 or other anti-obesity medications, or endocrine disorders that alter weight regulation);\n* inability to use a smartphone or complete remote study procedures;\n* participation in another weight loss or maintenance program or clinical trial judged by investigators to interfere with study involvement;\n* Adults unable to consent (cognitively impaired);\n* Wards of the state;\n* Anyone under age 18.","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","INTERVENTIONAL",[23],"NA","Many people who use GLP-1 medications (such as semaglutide or tirzepatide) achieve meaningful weight loss, but maintaining that weight loss off after stopping the medication can be very challenging. Researchers at Tufts University are conducting a study to learn whether a digital lifestyle program can help people maintain their weight loss after they stop taking a GLP-1 medication.\n\nAdults who have recently stopped a GLP-1 medication may be eligible to participate. Participants will be randomly assigned to either receive access to a digital program or to continue with usual care. The study lasts 12 months and is fully remote. All participants will receive a Bluetooth scale to track weight from home and will complete short online questionnaires several times over the year.\n\nBy taking part, participants can help researchers better understand how to support long-term weight maintenance in a way that is affordable, accessible, and sustainable. Participants are compensated for their time, and involvement may help improve care for others with similar experiences.",[26],"Weight Maintenance",[28,29,30,31,32,33,26,34],"Obesity","Overweight","Glucagon-Like Peptide-1 Receptor Agonists","Digital Health","Lifestyle Intervention","Mobile Applications","Eating Behavior","NOT_YET_RECRUITING","2026-07-14",{"date":38,"type":39},"2026-07-16","ACTUAL",{"date":41,"type":20},"2026-08-01",{"date":43,"type":20},"2028-07-31",{"name":45,"class":46},"Tufts University","OTHER"]